Initiating An AI-Assisted FDA Import Compliance Program

Join us and regulatory expert Tom Sidebottom for our webinar "Initiating an AI-Assisted FDA Import Compliance Program."

In the presentation, you will discover how artificial intelligence can address critical pain points in FDA import compliance, including supplier verification, document management, regulatory updates, and border clearance delays. This session will explore AI platforms that streamline these processes, offering practical solutions to enhance accuracy, reduce errors, and ensure compliance with evolving FDA regulations.

Designed for importers, regulatory professionals, and compliance officers, the webinar will highlight real-world case studies and provide actionable strategies for integrating AI tools into your workflows. We will explore the challenge and complexity of products subject to multiple Partner Government Agency regulations. Learn why starting small with AI adoption is crucial and why getting started now is essential to stay ahead in the rapidly evolving regulatory landscape. Don't miss this opportunity to transform your compliance program and avoid being left behind.

Speaker:

Tom Sidebottom has more than 30 years of experience with the Food and Drug Administration (FDA) and supporting regulatory laws and policies for the manufacturing and distribution of domestic and imported food, drugs, cosmetics, devices, and biologics to protect human and animal health. His core competencies include regulatory testing and compliance, technical consultation, laboratory operations, crisis management, auditing, safety and quality systems, and extraneous material identification and etiology.

Tom is the founder and principal consultant at Regulatory Science Consulting, LLC, where he leverages his deep regulatory expertise and diverse perspectives to provide high-quality and custom solutions to clients across various industries. He is passionate about exploring applications using AI and machine learning that can strengthen novel testing approaches, analyses, risk evaluations, and supporting data through system-based approaches of risks to satisfy regulatory standards and demonstrate compliance.